Outlook Therapeutics, Inc.
financial.report · SEC EDGAR
This page reproduces a recorded source event. It is not a live quote, forecast, recommendation or legal conclusion.
Event type
financial.report
Occurred
2025-09-30
Reported
2025-12-19
Disclosure lag
80 days
Context
links are based on the recorded entity type| Field | Recorded value |
|---|---|
| Entity | Outlook Therapeutics, Inc. |
| Source | SEC EDGAR ↗ |
| Source identifier | companyfacts/CIK0001649989/2026-07-26 |
| Event ID | #27693 |
Recorded payload
JSON payload as stored after parsing{
"accession": "0001104659-25-123264",
"canonical_covered": 12,
"canonical_total": 12,
"fiscal_period": "FY",
"fiscal_year": 2025,
"form": "10-K",
"mapped_tag_share": 0.04282115869017632,
"metrics": {
"cash_and_equivalents": 8083085,
"earnings_per_share_basic": -1.79,
"earnings_per_share_diluted": -1.79,
"gross_profit": 57205,
"net_income": -62424863,
"operating_cash_flow": -51829437,
"operating_income": -67061666,
"revenue": 1413535,
"shareholders_equity": -32187661,
"shares_outstanding": 53887233,
"total_assets": 18584183,
"total_liabilities": 50771844
},
"metrics_reported": 12,
"period_end": "2025-09-30"
}Source: SEC EDGAR · as of 2025-12-19T00:00:00Z